Header image

Impact Factor Journals 2022
Autoimmunity and Immunodeficiency in Severe SARS-CoV-2 Infection and Prolonged COVID-19.
Current Issues in Molecular Biology.
2022,
45(1),
33-50,
ISSN: 1467-3037,
PMID: 36661489,
MUC5B rs35705950 minor allele associates with older age and better survival in idiopathic pulmonary fibrosis.
Respirology.
2022,
ISSN: 1323-7799,
PMID: 36571111,
Synthesis and Structural Optimization of 2,7,9-Trisubstituted purin-8-ones as FLT3-ITD Inhibitors.
International Journal of Molecular Sciences.
2022,
23(24),
16169,
ISSN: 1422-0067,
PMID: 36555810,
Single-cell protein profiling defines cell populations associated with triple-negative breast cancer aggressiveness.
Molecular Oncology.
2022,
ISSN: 1574-7891,
PMID: 36550781,
Acute pre-exercise hydrogen rich water intake does not improve running performance at maximal aerobic speed in trained track and field runners: A randomized, double-blind, placebo-controlled crossover study.
PLoS One.
2022,
17(12),
e0279307,
ISSN: 1932-6203,
PMID: 36538554,
Dysregulation of Amino Acid, Lipid, and Acylpyruvate Metabolism in Idiopathic Intracranial Hypertension: A Non-targeted Case Control and Longitudinal Metabolomic Study.
Journal of Proteome Research.
2022,
22(4),
1127-1137,
ISSN: 1535-3893,
PMID: 36534069,
Clear Cell Mesotheliomas with Inactivating VHL Mutations and Near-Haploid Genomic Features.
Genes, Chromosomes & Cancer.
2022,
ISSN: 1045-2257,
PMID: 36515470,
Modulating the pharmacokinetic profile of Actinium-225-labeled macropa-derived radioconjugates by dual targeting of PSMA and albumin.
Theranostics.
2022,
12(17),
7203-7215,
ISSN: 1838-7640,
PMID: 36438496,
Cannabinoid receptor 2 expression in early-stage non-small cell lung cancers identifies patients with good prognosis and longer survival.
Translational Lung Cancer Research.
2022,
11(10),
2040-2050,
ISSN: 2218-6751,
PMID: 36386452,